Skip to main content
IPIC 2023)

IPIC 2023

2023 International Primary Immunodeficiencies Congress (IPIC) Annual Meeting

9 November 2023 | Rotterdam, The Netherlands

CSL Behring was proud to support the International Primary Immunodeficiencies Congress (IPIC) at their annual congress in Rotterdam in November 2023. Our participation included an educational sponsored symposium showcasing insightful perspectives from four field experts, Prof. Martin van Hagen, Prof. Silvia Sánchez-Ramón, Emily Carne and Ayesha Ilahli.

Personalisation In Disease: diagnosing, managing and empowering patients with primary immunodeficiency

Duration: 00:54:03
Prof. Martin van Hagen

Prof. Martin van Hagen

(Rotterdam, The Netherlands)

Welcome and introduction

00:00:00 – 00:03:31

Silvia Sanchez Ramon

Prof. Silvia Sánchez-Ramón

(Madrid, Spain)

Diagnosing immunodeficiency diseases with impaired antibody production: a clinician’s perspective

00:03:31 – 00:21:15

Emily Carne

Emily Carne

(Cardiff, UK)

Personalising the management of primary immunodeficiency with impaired antibody production using immunoglobulin pre-filled syringes: a nurse’s perspective.

00:21:15 – 00:37:30

Emily Carne

Ayesha Ilahi

(Cardiff, UK)

Personalising immunoglobulin administration: a patient’s perspective

00:37:30 – 00:42:07

Report an undesirable effect

If you encounter any side effect(s) to a CSL Behring product, we encourage you to talk to your doctor, pharmacist, or nurse.

CSL Behring collects information about undesirable effects in order to monitor product safety and investigate, evaluate and report undesirable effects to appropriate regulatory bodies. In the United States, patients experiencing negative side effects of prescription drugs are encouraged to report them to the FDA here, or by calling 1-800-FDA-1088.

Learn More

Jan 2024